AMCLERUS
Live / Registered — Registered (as of 03 Dec 2024)
What this means for you
Registered since 03 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79393086
- Registration number
- 7583220
- Mark type
- Stylized text
- Filed
- 02 Feb 2024
- Published for opposition
- 01 Oct 2024
- Registered
- 03 Dec 2024
Goods and services
- Class 005 — Pharmaceuticals: Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis, psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host and graft rejections, Alzheimer's and Parkinson's-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields
- Class 045 — Legal and security services: Licensing of intellectual property in the field of biotechnology
Owner
Prosecution history
- 19 Sept 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 03 Sept 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 03 Sept 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 02 Jan 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 03 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 01 Oct 2024 — PUBLISHED FOR OPPOSITION
- 11 Sept 2024 — NOTICE OF PUBLICATION
- 28 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Aug 2024 — ASSIGNED TO EXAMINER
- 19 Jul 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 12 Apr 2024 — APPLICATION FILING RECEIPT MAILED
- 08 Apr 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 Apr 2024 — SN ASSIGNED FOR SECT 66A APPL FROM IB